The impact of long-term lenalidomide exposure on the cellular composition of bone marrow

Leuk Lymphoma. 2014 Nov;55(11):2665-8. doi: 10.3109/10428194.2014.900765. Epub 2014 Apr 22.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bone Marrow / drug effects*
  • Bone Marrow / pathology
  • Flow Cytometry
  • Hematopoiesis / drug effects
  • Humans
  • Immunologic Factors / adverse effects
  • Immunologic Factors / therapeutic use
  • Lenalidomide
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / drug therapy*
  • Survival Analysis
  • Thalidomide / adverse effects
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Time Factors
  • Treatment Outcome
  • Young Adult

Substances

  • Immunologic Factors
  • Thalidomide
  • Lenalidomide